Saturday, September 14, 2024 12:42:57 PM
"Please describe in detail what happened with that company."
TSNP/HMBL over a short period with multiple news releases and at least 2 share cancellations went from .0005 to $1.93 in 3 months .
I will alway like this quote from someone who was there...."I was in Sharp’s last reverse merger ticker. I bought at .016, it ran to .359, I held almost all of it. It then went to .077, down 80%. I felt stupid, but I stayed the course. It ran to $1.93 and I won, selling shares along the way up."
and
""...reminds me of $HMBL in 2021 which went to $1.97 from .0008 cents … life changing for sure ! When i first discovered it at .02, got in with 500k shares and sold at .34 cents for a $160,000 in profits. "
Unfortunately it couldn't sustain the rise and 3 weeks later performed a 4 to 1 rev split and continued to fall back to penny status over the next year
Recent AIMN News
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
